Polaryx Therapeutics, Inc. (Nasdaq: PLYX) a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of novel, disease-modifying therapies for rare, ...
The recent update on Sociedad Química y Minera de Chile lifts the central fair value estimate from US$61.44 to US$74.00, backed by slightly lower discount rate assumptions and higher projected revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results